Cross-sectional imaging techniques are increasingly being used in the preoperative evaluation of patients with colorectal cancer. Both computed tomography (CT) and magnetic resonance (MR) imaging have been improved with significant advances of the technological hard-and software. This has contributed to high patient acceptance due to shorter examination times and more open configuration of the systems, consistent high quality images with better delineation of the normal abdomino-pelvic anatomy and pathology. New techniques such as CT-colonography have emerged from a research application to a clinical tool which can be used in different clinical settings. Phased-array receiver coils have significantly increased the usefulness of MR in the evaluation of rectal neoplasms due to the high resolution that can be obtained. New organ specific contrast agents for magnetic resonance imaging have facilitated the preoperative evaluation of liver metastases in favour of more invasive techniques with similar sensitivities. However, preoperative staging criteria for colorectal cancer using computed tomography and magnetic resonance imaging has to be updated and the results of new techniques have to be confirmed in large trials. In the future, further development of CT and MR may offer 'one-stop-shopping' protocols for both diagnosis, local and distant staging of colorectal cancer. Diffusion weighted MR-imaging, in vivo spectroscopy as well as further targeted imaging, such as with lymph node specific agents for MR may also prove to be helpful in the preoperative evaluation of patients with colorectal cancer.
INTRODUCTION
Since the beginning of the 1970's, when computed tomography (CT) and later magnetic resonance (MR) imaging were introduced as cross-sectional imaging modalities, there have been several developments that have widened their use to include a variety of frequently encountered body indications. While being used primarily for detection of distant metastases, recurrent disease and staging, it is only during recent years that CT and MR have been used for detection of the colorectal cancer.
CT was first among the two to become widely used for abdominal and pelvic imaging. Initial promising results for preoperative staging of rectal cancer with CT (1, 2) was later replaced by reports on limited accuracy to predict extrarectal disease and loco-regional adenopathy (3, 4) . Also with MR, results that indicated limited clinical usefulness in the local staging of rectal cancer were reported as late as the late 1990's (5). For local staging of colon cancer less data exists for local staging using CT and MR. The results of the so far largest multicentre trial in preoperative staging of colorectal cancer was performed in the US between 1989-1993 concluded in 365 patients that CT was more accurate than MR, particularly in the definition of penetration of muscularis propria by rectal cancer (74 % vs 58 %). Accuracies of assessing lymph node involvement reached 62 % and 64 % respectively and accuracies for evaluation of liver metastases reached 85 % with both methods (4). However, during the past decade, it is evident that the technological advances becoming available has improved both CT and MR since this study. Furthermore, there is increasing knowledge about more clinically relevant landmarks in the preoperative evaluation, such as the mesorectal fascia in rectal cancer staging (6, 7). New examination approaches such as thin slice CT-colongraphy, have also changed the indications for crosssectional imaging in colorectal cancer patients (8) .
In this overview, recent advances and todays use of preoperative CT and MR-imaging in colorectal cancer is summarised together with some illustrations of their clinical use.
COMPUTED TOMOGRAPHY
CT contributes to a large part of the recent increase in workload in large radiological departments. In addition to preoperative metastasis screening, CT is also used for dose planning before radiotherapy. Im-aging guided biopsy of lesions not readily accessible by ultrasonographic guidance can also be performed using CT, such as biopsy of adrenal and pelvic masses to confirm the presence of tumour recurrence.
Helical (spiral) CT with continuous scanning during table movement which was introduced during beginning of the 1990's has contributed both to shorter examination times and to increased patient through-put. Imaging quality has improved and new applications in body imaging have emerged due to spiral scanning. CT today probably offers the most reproducible way for cross-sectional abdominal imaging. Further development of spiral CT was introduced in the late 1990's when the possibility of using a row of multiple x-ray detectors each contributing to information during the rotation of the x-ray tube. The multi-detector CT scanners available today typically have 2 to 16 detectors. Multi-detector spiral CT can be used to increase scanning speed, reduce slice thickness or increase volume coverage.
As an example, the entire thorax and abdomen can be scanned with transverse sections during one single breath-hold using a four row CT scanner.
In a frail, elderly patient where a colorectal cancer is suspected, a CT examination also with a minimum of preparation is both tolerable for the patient and has a high diagnostic yield in this patient group (9). The radiologist may also be the first to diagnose colon cancer on CT in patients investigated for a variety of abdominal symptoms (10). CT-colonography in a patient with a polypoid tumour in the transverse colon (arrows). Depending on the window settings for viewing the images, either the interface between air and soft tissues (a) or the parenchymatous organs (b) can be evaluated. The thin sections are used to reformat the images into different cut-planes (c). The data can also be processed to generate a virtual colonoscopy (d).
CT COLONOGRAPHY
CT-colonography including virtual colonoscopy is one of the most important recent applications of cross-sectional imaging evolved during the last years (11) (12) (13) . In a recent study with questionnaires to patients and physicians, potential patients preferred virtual to conventional colonoscopy, whereas physicians favoured conventional colonoscopy (14) . So far these CT-examinations have required bowel preparation similar to that before a conventional colonoscopy or barium enema. After insertion of a rectal tube, the colon is filled with air. The entire colon is scanned with thin (1,25-5 mm) slices. The patient is scanned in both supine and prone position in order to improve overall distention of all parts of the colon and to improve separation of stools from lesions in the colonic wall (15) . The slices are used to generate a volume that can be reformatted in any plane. In a computer workstation, this volume is scrolled through in 'cut-planes' in the transverse, sagittal as well as coronal planes and space occupying lesions in the colon are visualised in the interface between the air and soft tissues. The 'cut-plane' technique is the most common way to examine the colon. This evaluation can be complemented by using volume rendering techniques where real-time computer generated 3D 'virtual colonoscopy' images with views similar to those in conventional colonoscopy are generated ( Fig. 1 ).
So far, indications for CT-colonography have mainly been screening for and detection of polyps in the colon (16) or examination after incomplete conventional colonoscopy (17) (18) (19) . However, the thin slices obtained during CT-colonography can also be useful in the preoperative staging of colorectal cancer. If the entire abdomen is examined in the same session, the liver and retroperitoneum can also be assessed as well as the primary tumour and detection of synchronous tumours in the colon. If intravenous contrast is administered, this can potentially not only improve evaluation of polyps (20) but also im-prove depiction of liver metastases (19) . In a recent study of 50 patients with a history of previous surgery for colorectal carcinoma, contrast-enhanced CT colonography was concluded to be a promising method for detecting local recurrence, metachronous disease, and distant metastases (21) .
In one study, CT-colonography was shown to have an overall staging accuracy of 81 percent for colorectal cancer and was superior to barium enema in visualizing colonic segments proximal to obstructing colorectal lesions (22) .
CT-colonography is still developing. Present research is directed towards obtaining thinner slices using multi-detector technology (23), reducing the radiation dose (24, 25) and investigation of methods to obviate the need for compete colonic cleansing, mostly based on tagging the faeces with oral suspension such as barium sulfate (26) (27) (28) . New methods dealing with how to improve usage of the large amount of image data in CT-colonography by computer aided diagnosis of polyps (29) (30) (31) or by automated segmentation of the colonic wall from adjacent tissues are also being developed (32) .
MAGNETIC RESONANCE IMAGING
The role of magnetic resonance in abdominal imaging has increased significantly during the past years. The intrinsic soft tissue contrast properties of this modality and the ability to detect fluid and fat in tissues can still not be surpassed by any other imaging modality (33) . In colorectal carcinoma, the contrast properties of MR is helpful in the diagnosis of mucinous tumours, mucin on MR-images exhibiting a characteristic signal intensity behaviour (Fig. 2 ).
The quality of magnetic resonance imaging is user dependent. The limitations of the technique are related to our knowledge and limited time to explore its possibilities. The number of referrals for abdominal MR to different institutions varies and depends on expertise in dedicated fields. Furthermore, despite technological advances and excellent image quality, MR imaging is yet not as reproducible an examination technique as computed tomography. The signal intensity in the image is also a relative measurement and not as quantitative as attenuation in CT. Patient acceptance and patient related image quality still tends to be more variable with MR than CT. In some patients, MR-imaging can not be performed, due to metallic implants such as pacemakers.
Still, the use of magnetic resonance imaging in colorectal cancer is increasing, especially in the evaluation of patients with rectal cancer (34) (35) (36) .
PREREQUIITES FOR ABDOMINAL MR-IMAGING
In order to ensure high-resolution images with enough signal to noise ratio, use of a superconductive high field-strength (at least 1.0 or preferably 1.5 T) magnet for imaging of the abdomen is advocated. The system should also be equipped with dedicated surface receiver coils for abdominal imaging. Multiple surface coils connected together in phasedarrays to separate receivers forming a single composite image can improve signal to noise ratio by up to a factor of two to three compared to the conventional single body coil (37-39) ( Fig. 3) . To obtain sub-millimeter in-plane resolution for abdominal studies, phased-array coils are necessary in 1.0-1.5 T systems. Phased-array coils have been available for a decade and are today commonly used for all abdominal magnetic resonance studies.
MAGNETIC RESONANCE IMAGING OF RECTAL CANCER
There are several reported studies on local staging of rectal cancer using MR at 1.5 T with external phased-array coils. Most of these studies have been performed using the TN-system with results confirmed by histopathological examination of the resected specimen (5, 40, [41] [42] [43] .
Using these techniques, it seems from the studies that penetration of the bowel wall by tumour can be predicted with 75-89 % accuracy and assessment of metastases of local lymph nodes metastases with a sensitivity and specificity which is 60-70 %. These figures are dependant on the experience of the observer as illustrated by the work by Beets-Tan and coworkers who found a rather moderate degree of agreement between the staging performed by two radiologists (7).
The perirectal (mesorectal) fascia or fascia propria of the rectum was described on CT twenty years ago (44) . The imaging importance of this fascia in rectal imaging has only recently become of interest (6, 36). Brown et al 1999 reported in a study of 28 patients using 3 mm slices in a plane perpendicular to the tumour that this fascia could be visualised in every case. Furthermore, the study showed a good correlation with the depth of extramural tumour extension on MR-images and the corresponding depth on histopathology. Beets-Tan and coworkers later reported in a study of 76 patients that a tumour-free distance of 1 and 2 mm to the mesorectal resection plane in the resected specimen could accurately be predicted if the distance on MR-images was found to be at least 5 and 6 mm respectively (7). In MRimaging of a male cadaver before and after extrafascial dissection of the rectum, Bissett and coworkers showed that the fascia that can be identified on MR was shown anatomically to be the fascia propria of the rectum. In a second study of 43 patients with rectal cancer using MR and defining the tumour extent as 'inside', 'up to' or 'through' they found that it was possible to predict if the tumour was contained within the mesorectum with an accuracy of 95 % with MR (45) . It was suggested that patients with tumours contained within the fascia propria are unlikely to develop a local recurrence if the rectum had been removed by an extrafascial excision. At our institution, pelvic MR-imaging with phased-array coils is part of the routine preoperative work-up of all patients with rectal cancer who do not have contraindications for MR ( Fig. 4) .
Some groups have advocated the use of rectal and intravenous contrast when staging rectal tumours using MR (41, 46) . In our experience, rectal contrast medium is of value only in a selected group of patients with recto-sigmoid tumours where the tumour and its cranio-caudal extension cannot be identified in collapsed segments of the bowel.
In locally advanced rectal cancer, MR-imaging seems to be the preoperative imaging modality of choice to exclude tumour infiltration to surgically important structures such as the pelvic side wall and other neighbouring organs in the pelvis (47, 48) . However, restaging of advanced tumours after radiochemotherapy has to be evalutated with consciousness because devitalised tumour tissue may be difficult to distinguish from active tumour on MR-images (49) . So fas CT seem not to be as accurate for evaluation of locally advanced rectal tumours (50, 51) , but recent advances with multiple detectors may show to improve results with CT in this group of patients in the future. What about endorectal coils for staging of rectal cancer with MR? The purpose when using an endoluminal coil is to increase the signal to noise ratio as much as possible in areas where this would not be possible with an external coil (Fig. 5 ). Endoluminal coils inserted into the rectum were first designed for prostate imaging (52) . Later studies using endorectal coils also seemed promising for rectal cancer staging (53) .
Some MR-equipment also offer the possibility of using simultaneous external phased-array coil together with an endorectal coil (54) . Endorectal coils are not suitable for all rectal tumours and care has to be taken when inserting such a coil into the rectum in a patient, especially in the presence of space occupying lesions (34) . Presently, endorectal coils have a limited role in the preoperative evaluation of colorectal cancer. There is one group from Berlin who found contrast-enhanced endorectal MR-imaging accurate both for local staging of rectal tumours compared to histopathology (55) . In a recent study the same group concluded contrast-enhanced endorectal MR-imaging to be promising for post therapeutical staging of rectal cancer and also helpful in the diagnosis of local recurrence compared to endorectal ultrasound (56) .
MR-COLONOGRAPHY
MR-imaging can also be used to obtain colonographic images. Multiple thin coronal sections during a breath-hold generate a volume image of the colon (57) . To achieve this, the magnet has to fulfil certain technical requirements. Furthermore, the optimal contrast medium has to be chosen. Air introduced into the bowel tends to generate interface artefacts with soft-tissues on MR. For this reason, fluid enemas with diluted Gadolinium chelates have been used (57) to obtain MR images of the colon. Water enemas and intravenous contrast agents have also been used for the same purpose (58) . Only recently, MR-colonography using either air (59) or CO 2 (60) inflated into the colon has also been shown to seem feasible. Pulse-sequences have to be properly optimised for each MR-system in order to be able to perform these examinations. Different protocols for MRcolonography are currently being evaluated and more time is needed for MR to become as widely used to perform colonography as CT. However, some reports in a limited numbers of patients are promising with regards both to detection and staging of colorectal cancer (61) .
In summary, MR-colonography is an investigation under development and its role in the preoperative evaluation of patients with colorectal cancer has yet to be established.
PREOPERATIVE LOCAL STAGING OF COLON CANCER
The role of cross-sectional modalities, mostly CT, for local staging of colon cancer has been considered lim-ited due to an inability to identify tumour spread through the bowel wall and to accurately predict the presence of local lymph node metastases. Indications to perform abdominal CT preoperatively include suspected haematogenous or paraortic metastases, suspected invasion of adjacent organs or abscess formation, atypical symptoms or unusual histological findings (eg. lymphoma) (10). Fig. 4 . Pelvic MR-images in a patient with a rectal tumour. On sagittal (a) and transaxial (b) T2-weighted images, the tumour and its extramural extension can be visualised (black arrows). The relation of the tumour to the mesorectal fascia and a lymph node deposit within the mesorectum (white arrow) can also be seen. 
PREOPERATIVE STAGING OF METASTATIC COLORECTAL CANCER
Spiral CT of the thorax and abdomen is efficient since both the extent of the primary tumour and local spread as well as distant metastases to the liver, lungs, adrenal glands and bones can be assessed in one single examination.
The liver is usually examined preoperatively in screening for metastases. Depending on local access and clinical routines, this evaluation is performed either by ultrasonography, CT or MR-imaging. In our institution, CT is the preferred first-line examination for screening of metastases of colorectal cancer before surgery of the primary tumour.
Dedicated methods, such as CT arterial portography (CTAP), where CT is performed during arterial injection of contrast media after selective catheterisation of the superior mesenteric artery, has been considered as one of the gold-standard methods for detection of focal liver lesions. This method is not so widely performed any more due to the development of CT and MR. Furthermore, irregular liver perfusion on CTAP may sometimes simulate focal liver lesions and result in false negative and false positive lesions (62) .
With multi-detector spiral CT it is technically possible to obtain 1 mm thick slices through the liver within a single breath-hold. Use of 2.5 mm thick slices compared to 5 and 10 mm slices has been reported to result in an increased sensitivity for detection of focal liver lesions with 18 and 46 % respectively (63) . Using thin slices also improves multiplanar reformations of the liver which can be useful for the surgical planning (Fig. 6) . With multi-detector CT, it is also possible to obtain angiographic images of the arterial supply to the liver by postprocessing images after an examination performed in precisely timed multiple phases after intravenous contrast injection. These angiographic images can be used before liver surgery to visualise the anatomy of the arterial vascular supply to the liver (64) .
Magnetic resonance imaging is gaining acceptance as the modality of choice for preoperative imaging of liver tumours (65) . At our institution these are most commonly metastases from colorectal cancer. Magnetic resonance imaging offers the advantage of being able not only to non-invasively characterise many of the benign liver tumours such as haemangioma, focal nodular hyperplasia and adenoma with high accuracy, but also to detect the extent of tumour spread within the liver with at least similar accuracy as CTAP. Several liver-specific contrast agents are now available on the market. There are both hepatocyte specific agents (Teslascan and Multihance) and contrast agents based on superparamagnetic iron ioxide particles (SPIO) targeted to the reticuloendothelial system, in the liver the Kuppfer cells (Endorem and Resovist). The latter of the two SPIO's, Resovist, can be administered as a bolus injection. Imaging 8-10 minutes after injection of the contrast agent shows a homogenous darkening of the liver due to uptake of the contrast agent where Kuppfer cells are present and increased visibility of liver metastases (Fig. 7) . Depending on the slice thickness used, this increased visibility also facilitates detection of metastases, even those which are less than 10 mm in diameter.
FOLLOW-UP AFTER SURGERY
There is to date no consensus regarding a follow-up program after surgery for colorectal cancer. There is also not yet enough data to tell which of the available radiological modalities is the best for this purpose. CT-colonography is one of the most recent studied modalities for this purpose (21) . In patients operated for rectal cancer, we advocate the use of MR for diagnosis of local recurrence (66) .
THE FUTURE
The provision of diagnostic resources tend to be limited by a planning process that is based on historical data concerning demands. In this sense, it is a challenge to use what we have today, based on what was needed yesterday, despite suddenly available technical developments that change what we can do tomorrow. Both CT and MR technology will continue to surprise us with possibilities that change the way routine examinations can be performed. Current trends in research on CT in colorectal cancer are likely to further increase overall performance and improve patient acceptance (67) . Protocols with significantly lower radiation doses than today are likely to become available and widely used. This is important if CT is going to be used for screening of colorectal cancer. CT has a potential to be performed as a single examination offering both diagnosis, local as well as metastasis staging in colorectal cancer. Integrated CT-positron emission tomography (CT-PET) scanners are also likely to prove valuable in the evaluation of patients with colorectal cancer.
As a consequence of new imaging algorithms, preoperative criteria for staging will need to be revised and made more uniform for both CT and MR. This is particularly obvious concerning rectal cancer staging with MR, to allow for accurate and comparable stratification of patients into different treatment between different institutions.
With MR, today's work with MR-colonography will be evaluated in more institutions also improving in performance and patient acceptance. MRcolonography will have to be compared to CTcolonography to define its role. Today's work with moving tables that allow whole-body MR imaging in one examination (68) will have to be evaluated in patients with colorectal cancer and compared to other whole body staging techniques such as CT/PET for staging of primary and recurrent disease.
More targeted contrast agents for MR-imaging will also be available, one of them being ultrasmall iron ioxide particles (USPIO's) that are phagocytosed by parts of the reticulo-endothelial system in normally functioning and inflamed lymph nodes. Sinerem, a USPIO, is currently being evaluated with promising results for lymph node staging in head and neck cancers (69) and for evaluation of axillary nodes in breast cancer (70) . If this contrast agent will improve lymph node staging in colorectal cancer remains to be seen.
Functional magnetic resonance imaging techniques have been evaluated for many years and continue to develop and increase in numbers but are still not simple enough to be incorporated into everyday clinical practice in most centres. Despite this, both with and without contrast agents, the potential with MR is tremendous in terms of studying microvascular properties of tumours, the degree of necrosis and metabolites that corresponds to tumour aggressiveness using perfusion, diffusion and in vivo spectroscopy techniques (71, 72, 73) . The fact that these techniques require much work from teams of dedicated physicists, radiologists and technicians limits their use so far.
CONCLUDING REMARKS
Advances in CT and MR imaging during the last years have markedly changed the way that patients with colorectal cancer are being evaluated. These new techniques may today generate nearly 1000 images in one single study. To be able to view, post process and evaluate all of these images, very powerful workstations and data storage systems are needed. The organisation of work, including ways of communicating, not only between surgeons and radiologists, but also regular multidisciplinary conferences will further improve the use of these modalities. Finally, it is very important to consider the local radiological expertise generated by experience and Fig. 7 . T2-weighted MR-images before (left row) and after intravenous injection of a superparamagnetic iron ioxide contrast agent (Resovist). In a patient with liver metastases from colon cancer. After injection, the liver becomes dark due to uptake of the agent within the Kuppfer cells. Since there is no uptake within the metastases, these become more visible after injection (white arrows). participation in multidisciplinary teams when considered choice of different imaging techniques is to be achieved.
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